2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $195,898 | -44.1% | 49,974 | +44.4% | 0.00% | – |
Q2 2023 | $350,273 | +15.1% | 34,612 | +16.0% | 0.00% | – |
Q1 2023 | $304,337 | +8.9% | 29,837 | 0.0% | 0.00% | – |
Q4 2022 | $279,573 | +27.9% | 29,837 | +98.7% | 0.00% | – |
Q3 2022 | $218,526 | +16.2% | 15,019 | +5.7% | 0.00% | – |
Q2 2022 | $188,000 | -16.4% | 14,211 | +62.2% | 0.00% | – |
Q4 2021 | $225,000 | – | 8,761 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |